Emma Ballard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emma Ballard has a total of 348 co-authors. Here are the top co-authors by number of shared publications:
- Scott Cameron Bell
Gold Coast University Hospital, Southport, Australia
11 shared publications - Timothy James Kidd
Central Microbiology, Pathology Queensland, Royal Brisbane and Women’s Hospital, Herston, QLD 4029, Australia
8 shared publications - Alka Kothari
Faculty of Health, Medicine and Behavioural Sciences University of Queensland Brisbane Queensland Australia
7 shared publications - Claire Elizabeth Wainwright
Department of Respiratory and Sleep Medicine, Queensland Children’s Hospital, South Brisbane, Queensland, Australia
7 shared publications - Luke David Knibbs
Sydney School of Public Health, The University of Sydney, Camperdown, NSW 2050, Australia
7 shared publications - Rebecca Elizabeth Stockwell
Lung Bacteria Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
7 shared publications
Latest Publications
- Open Access
- 14 January 2026
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 39 (3) , 403-409
Presence And Laterality Of Endometriosis In Adolescent Patients With Obstructed Müllerian Duct Anomalies, A Twenty-Three Year Retrospective Cohort Analysis Between 2002 – 2025 At An Australian Quaternary Paediatric And Adolescent Gynaecology Service
- 14 January 2026
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 39 (3) , 403-409
Open AccessPresence And Laterality Of Endometriosis In Adolescent Patients With Obstructed Müllerian Duct Anomalies, A Twenty-Three Year Retrospective Cohort Analysis Between 2002 – 2025 At An Australian Quaternary Paediatric And Adolescent Gynaecology Service
- Open Access
- 25 November 2025
- Published by Wiley
Rotational thromboelastometry (ROTEM®) and platelet function as measured by Multiplate® in pre-eclamptic women: A prospective observational study.
Objective: Pre-eclampsia with thrombocytopaenia has implications for obstetric haemorrhage management. We aimed to describe coagulation and platelet function in women with pre-eclampsia and compare the results with those from women without pre-eclampsia. Design: A prospective, observational study. Setting: Tertiary referral hospital. Population: Women with clinically diagnosed pre-eclampsia compared to those with uncomplicated pregnancies (comparator group). Methods: We obtained pre-delivery coagulation results from pregnant women. The pre-eclampsia group had confirmed or suspected pre-eclampsia and blood samples collected on admission to birth suite. The comparator group had uncomplicated pregnancies and blood samples obtained prior to elective Caesarean delivery. Main Outcome Measures: Multiplate® and non-activated thromboelastometry (ROTEM® NATEM) results were compared between groups and with manufacturer’s reference ranges. Results: One hundred and nineteen women with pre-eclampsia were compared to 22 in the comparator group. The mean values for selected ROTEM® parameters for the pre-eclampsia and comparator groups respectively were: ROTEM® NATEM amplitudes A5, 49 and 45 mm (P=0.035); A10, 61 and 57 mm (P=0.017); A15, 65 and 62 mm (P=0.02); A20, 67 and 64 mm (P=0.026); A25, 69 and 65 (P=0.009); A30, 69 and 66 (P=0.023); area under curve (AUC), 6877 and 6642 mm 2 (P=0.044); maximum clot firmness (MCE), 230 and 201 (P=0.018) and thrombin potential index (TPI), 76 and 60 (P=0.029). Conclusions: ROTEM® values from the pre-eclampsia group indicated increased hypercoagulability compared to the comparator group, however Multiplate® parameters measuring platelet function, were not significantly different between groups.
- 25 November 2025
- Published by Wiley
Open AccessRotational thromboelastometry (ROTEM®) and platelet function as measured by Multiplate® in pre-eclamptic women: A prospective observational study.
Objective: Pre-eclampsia with thrombocytopaenia has implications for obstetric haemorrhage management. We aimed to describe coagulation and platelet function in women with pre-eclampsia and compare the results with those from women without pre-eclampsia. Design: A prospective, observational study. Setting: Tertiary referral hospital. Population: Women with clinically diagnosed pre-eclampsia compared to those with uncomplicated pregnancies (comparator group). Methods: We obtained pre-delivery coagulation results from pregnant women. The pre-eclampsia group had confirmed or suspected pre-eclampsia and blood samples collected on admission to birth suite. The comparator group had uncomplicated pregnancies and blood samples obtained prior to elective Caesarean delivery. Main Outcome Measures: Multiplate® and non-activated thromboelastometry (ROTEM® NATEM) results were compared between groups and with manufacturer’s reference ranges. Results: One hundred and nineteen women with pre-eclampsia were compared to 22 in the comparator group. The mean values for selected ROTEM® parameters for the pre-eclampsia and comparator groups respectively were: ROTEM® NATEM amplitudes A5, 49 and 45 mm (P=0.035); A10, 61 and 57 mm (P=0.017); A15, 65 and 62 mm (P=0.02); A20, 67 and 64 mm (P=0.026); A25, 69 and 65 (P=0.009); A30, 69 and 66 (P=0.023); area under curve (AUC), 6877 and 6642 mm 2 (P=0.044); maximum clot firmness (MCE), 230 and 201 (P=0.018) and thrombin potential index (TPI), 76 and 60 (P=0.029). Conclusions: ROTEM® values from the pre-eclampsia group indicated increased hypercoagulability compared to the comparator group, however Multiplate® parameters measuring platelet function, were not significantly different between groups.
- Open Access
- 17 November 2025
- Published by Elsevier in Women and Birth
- Vol. 39 (1) , 102134
Use of the Rebozo in second stage labour to reduce the incidence of assisted vaginal births for nulliparous women: A pilot randomised controlled trial
- 17 November 2025
- Published by Elsevier in Women and Birth
- Vol. 39 (1) , 102134
Open AccessUse of the Rebozo in second stage labour to reduce the incidence of assisted vaginal births for nulliparous women: A pilot randomised controlled trial
- Open Access
- 8 November 2025
- Published by Elsevier in Australasian Emergency Care
- Vol. 29 (2) , 182-188
Practice variations in pharmacological management of acute renal colic pain: A cross-sectional survey study
- 8 November 2025
- Published by Elsevier in Australasian Emergency Care
- Vol. 29 (2) , 182-188
Open AccessPractice variations in pharmacological management of acute renal colic pain: A cross-sectional survey study
- Open Access
- 14 July 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (8) , 1462-1475
Source control in bloodstream infections in patients with sepsis, septic shock, or requiring ICU admission: a scoping review with recommendations for standardizing research
Background Bloodstream infections (BSI) account for 15% of intensive care unit (ICU) infections, often causing sepsis with mortality rates up to 50%. Source control (SC), encompassing interventions to reduce bacterial or fungal load and prevent infection spread, is a critical yet under-investigated component of management. Objectives This scoping review examines SC definitions, interventions, timing, adequacy, and outcomes in BSI literature in patients with sepsis, septic shock, or ICU admission, and offers a proposal for standardized reporting. Methods We searched Medline, EMBASE, and Cochrane Library for studies on adult BSI addressing SC in populations with ≥ 50% ICU admission, ≥ 75% sepsis, or ≥ 25% septic shock, extracted and reported data following established guidance. Results From 2193 abstracts, 77 studies were included. SC was a primary objective in 21%, with others reporting it alongside other objectives. Candidemia (47%) and catheter removal (60%) studies were predominant, with 34% evaluating catheter removal regardless of BSI source. SC definitions varied from no definition (8%), minimal (7%), concise (17%), comprehensive (9%) definitions and catheter removal (60%). Forty-seven % reported proportions receiving SC for the entire cohort rather than those requiring SC. Timing was reported by 68%, with inconsistent definitions. SC adequacy was assessed by 3%. SC improved outcomes in 65%, with no reported harm. Conclusion SC research in severe BSI is limited by inconsistent definitions, poor SC efficacy assessments, and overrepresentation of catheter-source BSI and candidemia. Standardized reporting is essential to enhance evidence quality and optimize BSI management in critically ill patients.
- 14 July 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (8) , 1462-1475
Open AccessSource control in bloodstream infections in patients with sepsis, septic shock, or requiring ICU admission: a scoping review with recommendations for standardizing research
Background Bloodstream infections (BSI) account for 15% of intensive care unit (ICU) infections, often causing sepsis with mortality rates up to 50%. Source control (SC), encompassing interventions to reduce bacterial or fungal load and prevent infection spread, is a critical yet under-investigated component of management. Objectives This scoping review examines SC definitions, interventions, timing, adequacy, and outcomes in BSI literature in patients with sepsis, septic shock, or ICU admission, and offers a proposal for standardized reporting. Methods We searched Medline, EMBASE, and Cochrane Library for studies on adult BSI addressing SC in populations with ≥ 50% ICU admission, ≥ 75% sepsis, or ≥ 25% septic shock, extracted and reported data following established guidance. Results From 2193 abstracts, 77 studies were included. SC was a primary objective in 21%, with others reporting it alongside other objectives. Candidemia (47%) and catheter removal (60%) studies were predominant, with 34% evaluating catheter removal regardless of BSI source. SC definitions varied from no definition (8%), minimal (7%), concise (17%), comprehensive (9%) definitions and catheter removal (60%). Forty-seven % reported proportions receiving SC for the entire cohort rather than those requiring SC. Timing was reported by 68%, with inconsistent definitions. SC adequacy was assessed by 3%. SC improved outcomes in 65%, with no reported harm. Conclusion SC research in severe BSI is limited by inconsistent definitions, poor SC efficacy assessments, and overrepresentation of catheter-source BSI and candidemia. Standardized reporting is essential to enhance evidence quality and optimize BSI management in critically ill patients.
- 1 July 2025
- Published by Elsevier in Australian Critical Care
- Vol. 38 (5) , 101273
Improving energy and protein intake via an oral nutrition support pathway in the intensive care unit and beyond: An uncontrolled before and after study
- 1 July 2025
- Published by Elsevier in Australian Critical Care
- Vol. 38 (5) , 101273
Improving energy and protein intake via an oral nutrition support pathway in the intensive care unit and beyond: An uncontrolled before and after study
- 21 May 2025
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 59 (7) , 602-611
Increases in delivery of a brief smoking cessation intervention following implementation of a system change intervention in community psychiatry settings
Objective: Tobacco-related disease is a leading cause of premature mortality for people experiencing mental illness. Tobacco treatment is not routinely provided in psychiatry with systemic barriers preventing access to treatment. This study examines a system change approach, with an incentive payment, to implement tobacco treatment at scale in community psychiatry settings. Methods: Secondary analysis of statewide health administrative data was conducted. Changes in documentation of smoking status and delivery of a tobacco treatment brief intervention (the Pathway) were evaluated using interrupted time series analysis between July 2017 and June 2023. An implementation period (4 years), divided into incentive payment phases for achievement of pre-defined targets, and a post-incentive payment maintenance period (2 years) were defined. Results: Documented average smoking rate for community psychiatry during maintenance remained high (52.5%; 95% confidence interval = [52.5, 52.6]). Statewide documentation of smoking status significantly exceeded targets during implementation, reaching 93.9% (95% confidence interval = [93.3%, 94.4%]). Despite a 2.1% decrease (95% confidence interval = [−3.4, −0.8]) after removal of incentive payments, reporting remained high 91.9% (95% confidence interval = [91.5%, 92.3%]). Documentation of the Pathway was significantly higher than targets and showed no change by implementation end (87.0%; 95% confidence interval = [85.9%, 88.1%]) to maintenance where no incentive payments were available (85.7%; 95% confidence interval = [84.9%, 86.5%]). Conclusions: Delivery of tobacco treatment in psychiatry is an important step to addressing inequity in smoking prevalence, but achieving this has been challenging. Our study demonstrates the potential of a system change intervention to improve care and sustainably deliver tobacco cessation treatment, at scale, in psychiatry settings.
- 21 May 2025
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 59 (7) , 602-611
Increases in delivery of a brief smoking cessation intervention following implementation of a system change intervention in community psychiatry settings
Objective: Tobacco-related disease is a leading cause of premature mortality for people experiencing mental illness. Tobacco treatment is not routinely provided in psychiatry with systemic barriers preventing access to treatment. This study examines a system change approach, with an incentive payment, to implement tobacco treatment at scale in community psychiatry settings. Methods: Secondary analysis of statewide health administrative data was conducted. Changes in documentation of smoking status and delivery of a tobacco treatment brief intervention (the Pathway) were evaluated using interrupted time series analysis between July 2017 and June 2023. An implementation period (4 years), divided into incentive payment phases for achievement of pre-defined targets, and a post-incentive payment maintenance period (2 years) were defined. Results: Documented average smoking rate for community psychiatry during maintenance remained high (52.5%; 95% confidence interval = [52.5, 52.6]). Statewide documentation of smoking status significantly exceeded targets during implementation, reaching 93.9% (95% confidence interval = [93.3%, 94.4%]). Despite a 2.1% decrease (95% confidence interval = [−3.4, −0.8]) after removal of incentive payments, reporting remained high 91.9% (95% confidence interval = [91.5%, 92.3%]). Documentation of the Pathway was significantly higher than targets and showed no change by implementation end (87.0%; 95% confidence interval = [85.9%, 88.1%]) to maintenance where no incentive payments were available (85.7%; 95% confidence interval = [84.9%, 86.5%]). Conclusions: Delivery of tobacco treatment in psychiatry is an important step to addressing inequity in smoking prevalence, but achieving this has been challenging. Our study demonstrates the potential of a system change intervention to improve care and sustainably deliver tobacco cessation treatment, at scale, in psychiatry settings.
- 29 January 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 368-373
Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosis
- 29 January 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 368-373
Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosis